Maurice Reimann

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19.

Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19.

Journal: Nature
Published: February 05, 2025

Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.

Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control.

Journal: Nature communications
Published: September 30, 2024

Cellular senescence: Neither irreversible nor reversible.

Cellular senescence: Neither irreversible nor reversible.

Journal: The Journal of experimental medicine
Published: November 19, 2023

An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

Journal: Blood cancer discovery
Published: January 15, 2021

Virus-induced senescence is a driver and therapeutic target in COVID-19.

Virus-induced senescence is a driver and therapeutic target in COVID-19.

Journal: Nature
Published: January 10, 2021

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.

Journal: Blood
Published: February 10, 2020

H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients.

H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients.

Journal: Nature communications
Published: August 07, 2019

Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.

Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.

Journal: Cancer cell
Published: April 11, 2018

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma.

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma.

Journal: Blood
Published: February 19, 2016

Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.

Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.

Journal: Cancer cell
Published: December 26, 2015

B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.

B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.

Journal: Blood
Published: November 30, 2015

Senescence-associated reprogramming promotes cancer stemness.

Senescence-associated reprogramming promotes cancer stemness.

Journal: Nature
Published: February 16, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026